Arrowhead (ARWR) is up 9.7%, or $5.64 to $63.59.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ARWR:
- Arrowhead receives Breakthrough Therapy designation for plozasiran
- Arrowhead price target raised to $85 from $80 at H.C. Wainwright
- Arrowhead price target raised to $62 from $42 at BofA
- Arrowhead falls -8.3%
- Arrowhead Pharmaceuticals at Risk: Potential Generic Competition Threatens REDEMPLO’s Market Exclusivity